Close Menu

NEW YORK (360Dx) – Ascenda Biosciences said today that it has acquired proteomic diagnostic firm Provista Diagnostics.

With the purchase, Alpharetta, Georgia-based Ascenda acquired New York City-headquartered Provista's Videssa Breast test, a blood-based proteomic test for assessing whether women with indeterminate mammogram readings should receive a biopsy or can be safely monitored without immediate follow-up.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.